ID: ALA2070523

Max Phase: Preclinical

Molecular Formula: C26H35N2O11P

Molecular Weight: 582.54

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1ccc(OP(=O)(N[C@@H](C)C(=O)OCc2ccccc2)O[C@H]2[C@H](O)[C@@H](CO)O[C@H](OC)[C@@H]2NC(C)=O)cc1

Standard InChI:  InChI=1S/C26H35N2O11P/c1-16(25(32)36-15-18-8-6-5-7-9-18)28-40(33,38-20-12-10-19(34-3)11-13-20)39-24-22(27-17(2)30)26(35-4)37-21(14-29)23(24)31/h5-13,16,21-24,26,29,31H,14-15H2,1-4H3,(H,27,30)(H,28,33)/t16-,21+,22+,23+,24+,26-,40?/m0/s1

Standard InChI Key:  LOMLYAZTBWZFRF-HUSOZMOHSA-N

Associated Targets(non-human)

Cartilage 29 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 582.54Molecular Weight (Monoisotopic): 582.1978AlogP: 1.52#Rotatable Bonds: 13
Polar Surface Area: 171.11Molecular Species: NEUTRALHBA: 11HBD: 4
#RO5 Violations: 2HBA (Lipinski): 13HBD (Lipinski): 4#RO5 Violations (Lipinski): 2
CX Acidic pKa: 10.22CX Basic pKa: CX LogP: 0.74CX LogD: 0.74
Aromatic Rings: 2Heavy Atoms: 40QED Weighted: 0.20Np Likeness Score: 0.58

References

1. Serpi M, Bibbo R, Rat S, Roberts H, Hughes C, Caterson B, Alcaraz MJ, Gibert AT, Verson CR, McGuigan C..  (2012)  Novel phosphoramidate prodrugs of N-acetyl-(D)-glucosamine with antidegenerative activity on bovine and human cartilage explants.,  55  (10): [PMID:22501024] [10.1021/jm300074y]

Source